$FICO
Fair Isaac Corp

2021 Q4 Form 10-Q Financial Statement

#000081454722000003 Filed on January 27, 2022

View on sec.gov

Income Statement

Concept 2021 Q4 2020 Q4
Revenue $322.4M $312.4M
YoY Change 3.18% 4.66%
Cost Of Revenue $69.20M $89.53M
YoY Change -22.7% -1.36%
Gross Profit $253.2M $222.9M
YoY Change 13.58% 7.29%
Gross Profit Margin 78.53% 71.34%
Selling, General & Admin $98.05M $93.91M
YoY Change 4.41% -16.17%
% of Gross Profit 38.73% 42.13%
Research & Development $38.98M $40.65M
YoY Change -4.11% 4.39%
% of Gross Profit 15.4% 18.24%
Depreciation & Amortization $5.227M $7.026M
YoY Change -25.6% -10.57%
% of Gross Profit 2.06% 3.15%
Operating Expenses $137.0M $134.6M
YoY Change 1.83% -10.86%
Operating Profit $115.6M $94.72M
YoY Change 22.03% 82.57%
Interest Expense $12.20M $9.641M
YoY Change 26.49% -1.3%
% of Operating Profit 10.55% 10.18%
Other Income/Expense, Net $1.429M $2.880M
YoY Change -50.38% -1415.07%
Pretax Income $104.8M $87.96M
YoY Change 19.17% 109.95%
Income Tax $19.86M $1.468M
% Of Pretax Income 18.95% 1.67%
Net Earnings $84.96M $86.49M
YoY Change -1.77% 57.48%
Net Earnings / Revenue 26.36% 27.69%
Basic Earnings Per Share $3.13 $2.97
Diluted Earnings Per Share $3.09 $2.90
COMMON SHARES
Basic Shares Outstanding 27.17M shares 29.13M shares
Diluted Shares Outstanding 27.52M shares 29.79M shares

Balance Sheet

Concept 2021 Q4 2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $162.2M $144.7M
YoY Change 12.06% 30.13%
Cash & Equivalents $162.2M $144.7M
Short-Term Investments
Other Short-Term Assets $39.68M $53.20M
YoY Change -25.42% -21.88%
Inventory
Prepaid Expenses
Receivables $260.2M $310.6M
Other Receivables $0.00 $0.00
Total Short-Term Assets $462.0M $508.4M
YoY Change -9.13% 10.29%
LONG-TERM ASSETS
Property, Plant & Equipment $70.66M $95.00M
YoY Change -25.62% -34.3%
Goodwill $787.3M $817.8M
YoY Change -3.73% 0.61%
Intangibles
YoY Change
Long-Term Investments $35.24M $29.80M
YoY Change 18.26% 17.32%
Other Assets $87.99M $102.5M
YoY Change -14.12% 25.57%
Total Long-Term Assets $1.001B $1.068B
YoY Change -6.28% -1.44%
TOTAL ASSETS
Total Short-Term Assets $462.0M $508.4M
Total Long-Term Assets $1.001B $1.068B
Total Assets $1.463B $1.577B
YoY Change -7.2% 2.06%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $20.42M $21.75M
YoY Change -6.1% -33.03%
Accrued Expenses $75.07M $49.25M
YoY Change 52.41% 14.25%
Deferred Revenue $98.40M $115.8M
YoY Change -15.03% 0.96%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $65.00M $131.0M
YoY Change -50.38% -28.3%
Total Short-Term Liabilities $321.8M $391.0M
YoY Change -17.71% -11.54%
LONG-TERM LIABILITIES
Long-Term Debt $1.568B $739.8M
YoY Change 111.99% -0.51%
Other Long-Term Liabilities $60.55M $52.05M
YoY Change 16.32% -56.07%
Total Long-Term Liabilities $60.55M $52.05M
YoY Change 16.32% -93.96%
TOTAL LIABILITIES
Total Short-Term Liabilities $321.8M $391.0M
Total Long-Term Liabilities $60.55M $52.05M
Total Liabilities $2.002B $1.253B
YoY Change 59.78% -3.94%
SHAREHOLDERS EQUITY
Retained Earnings $2.670B $2.280B
YoY Change 17.13% 13.32%
Common Stock $1.208B $1.146B
YoY Change 5.45% -0.2%
Preferred Stock
YoY Change
Treasury Stock (at cost) $4.339B $3.036B
YoY Change 42.94% 6.77%
Treasury Stock Shares 62.35M shares 59.62M shares
Shareholders Equity -$538.3M $324.1M
YoY Change
Total Liabilities & Shareholders Equity $1.463B $1.577B
YoY Change -7.2% 2.06%

Cashflow Statement

Concept 2021 Q4 2020 Q4
OPERATING ACTIVITIES
Net Income $84.96M $86.49M
YoY Change -1.77% 57.48%
Depreciation, Depletion And Amortization $5.227M $7.026M
YoY Change -25.6% -10.57%
Cash From Operating Activities $124.9M $77.95M
YoY Change 60.21% 29.13%
INVESTING ACTIVITIES
Capital Expenditures $895.0K $3.045M
YoY Change -70.61% -53.15%
Acquisitions
YoY Change
Other Investing Activities $0.00 $210.0K
YoY Change -100.0% -481.82%
Cash From Investing Activities -$1.272M $3.862M
YoY Change -132.94% -142.86%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $482.8M $50.01M
YoY Change 865.3% -16.66%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -$155.4M -$99.81M
YoY Change 55.73% 107.09%
NET CHANGE
Cash From Operating Activities $124.9M $77.95M
Cash From Investing Activities -$1.272M $3.862M
Cash From Financing Activities -$155.4M -$99.81M
Net Change In Cash -$33.20M -$12.73M
YoY Change 160.74% -365.8%
FREE CASH FLOW
Cash From Operating Activities $124.9M $77.95M
Capital Expenditures $895.0K $3.045M
Free Cash Flow $124.0M $74.90M
YoY Change 65.53% 39.06%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q4 dei Entity Central Index Key
EntityCentralIndexKey
0000814547
CY2021Q4 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--09-30
CY2021Q4 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2021Q4 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2021Q4 dei Amendment Flag
AmendmentFlag
false
CY2021Q4 dei Document Type
DocumentType
10-Q
CY2021Q4 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2021Q4 dei Document Period End Date
DocumentPeriodEndDate
2021-12-31
CY2021Q4 dei Document Transition Report
DocumentTransitionReport
false
CY2021Q4 dei Entity File Number
EntityFileNumber
1-11689
CY2021Q4 dei Entity Registrant Name
EntityRegistrantName
Fair Isaac Corp
CY2021Q4 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2021Q4 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
94-1499887
CY2021Q4 dei Entity Address Address Line1
EntityAddressAddressLine1
5 West Mendenhall, Suite 105
CY2021Q4 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
59715
CY2021Q4 dei Entity Address City Or Town
EntityAddressCityOrTown
Bozeman,
CY2021Q4 dei Entity Address State Or Province
EntityAddressStateOrProvince
MT
CY2021Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
43513000 USD
CY2021Q4 dei City Area Code
CityAreaCode
406
CY2021Q4 dei Local Phone Number
LocalPhoneNumber
982-7276
CY2021Q4 dei Security12b Title
Security12bTitle
Common Stock, $0.01 par value per share
CY2021Q4 dei Trading Symbol
TradingSymbol
FICO
CY2021Q4 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2021Q4 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2021Q4 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021Q4 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2021Q4 dei Entity Small Business
EntitySmallBusiness
false
CY2021Q4 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2021Q4 dei Entity Shell Company
EntityShellCompany
false
CY2022Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
26279614 shares
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
162157000 USD
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
195354000 USD
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
260161000 USD
CY2021Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
312107000 USD
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
39678000 USD
CY2021Q4 us-gaap Assets Current
AssetsCurrent
461996000 USD
CY2021Q3 us-gaap Assets Current
AssetsCurrent
550974000 USD
CY2021Q4 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
33926000 USD
CY2021Q3 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
31884000 USD
CY2021Q4 us-gaap Other Investments
OtherInvestments
1316000 USD
CY2021Q3 us-gaap Other Investments
OtherInvestments
1312000 USD
CY2021Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
24597000 USD
CY2021Q3 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
27913000 USD
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
46061000 USD
CY2021Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
47275000 USD
CY2021Q4 us-gaap Goodwill
Goodwill
787259000 USD
CY2021Q3 us-gaap Goodwill
Goodwill
788185000 USD
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
3558000 USD
CY2021Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
4099000 USD
CY2021Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
16612000 USD
CY2021Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
20549000 USD
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
87985000 USD
CY2021Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
95585000 USD
CY2021Q4 us-gaap Assets
Assets
1463310000 USD
CY2021Q3 us-gaap Assets
Assets
1567776000 USD
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
20422000 USD
CY2021Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
20749000 USD
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
62926000 USD
CY2021Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
103506000 USD
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
75068000 USD
CY2021Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
79535000 USD
CY2021Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
98381000 USD
CY2021Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
105417000 USD
CY2021Q4 us-gaap Debt Current
DebtCurrent
65000000 USD
CY2021Q3 us-gaap Debt Current
DebtCurrent
250000000 USD
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
321797000 USD
CY2021Q3 us-gaap Liabilities Current
LiabilitiesCurrent
559207000 USD
CY2021Q4 us-gaap Long Term Debt
LongTermDebt
1568292000 USD
CY2021Q3 us-gaap Long Term Debt
LongTermDebt
1009018000 USD
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
50972000 USD
CY2021Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
53670000 USD
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
60548000 USD
CY2021Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
56823000 USD
CY2021Q4 us-gaap Liabilities
Liabilities
2001609000 USD
CY2021Q3 us-gaap Liabilities
Liabilities
1678718000 USD
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2021Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q4 us-gaap Preferred Stock Value Outstanding
PreferredStockValueOutstanding
0 USD
CY2021Q3 us-gaap Preferred Stock Value Outstanding
PreferredStockValueOutstanding
0 USD
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
88857000 shares
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
88857000 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
26509000 shares
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
27568000 shares
CY2021Q4 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
265000 USD
CY2021Q3 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
276000 USD
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1208365000 USD
CY2021Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
115586000 USD
CY2021Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1237348000 USD
CY2021Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
62348000 shares
CY2021Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
61289000 shares
CY2021Q4 us-gaap Treasury Stock Value
TreasuryStockValue
4339039000 USD
CY2021Q3 us-gaap Treasury Stock Value
TreasuryStockValue
3857855000 USD
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
2670102000 USD
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
2585143000 USD
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-77992000 USD
CY2021Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-75854000 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-538299000 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-110942000 USD
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1463310000 USD
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1567776000 USD
CY2021Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
322361000 USD
CY2020Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
312414000 USD
CY2021Q4 us-gaap Cost Of Revenue
CostOfRevenue
69203000 USD
CY2020Q4 us-gaap Cost Of Revenue
CostOfRevenue
89528000 USD
CY2021Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
38980000 USD
CY2020Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
40651000 USD
CY2021Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
98048000 USD
CY2020Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
93911000 USD
CY2021Q4 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
544000 USD
CY2020Q4 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
937000 USD
CY2021Q4 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
0 USD
CY2020Q4 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
7334000 USD
CY2021Q4 us-gaap Costs And Expenses
CostsAndExpenses
206775000 USD
CY2020Q4 us-gaap Costs And Expenses
CostsAndExpenses
217693000 USD
CY2020Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
94721000 USD
CY2021Q4 us-gaap Interest Expense
InterestExpense
12195000 USD
CY2020Q4 us-gaap Interest Expense
InterestExpense
9641000 USD
CY2021Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1429000 USD
CY2020Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2880000 USD
CY2021Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
104820000 USD
CY2020Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
87960000 USD
CY2021Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
19861000 USD
CY2020Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1468000 USD
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
84959000 USD
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
86492000 USD
CY2021Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-2138000 USD
CY2020Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
17048000 USD
CY2021Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
82821000 USD
CY2020Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
103540000 USD
CY2021Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.13
CY2020Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.97
CY2021Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.09
CY2020Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.90
CY2021Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
27167000 shares
CY2020Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
29127000 shares
CY2021Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
27524000 shares
CY2020Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
29789000 shares
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-110942000 USD
CY2021Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
29878000 USD
CY2021Q4 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-46474000 USD
CY2021Q4 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
493582000 USD
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
84959000 USD
CY2021Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-2138000 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-538299000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
331082000 USD
CY2020Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
25132000 USD
CY2020Q4 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-85622000 USD
CY2020Q4 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
50011000 USD
CY2020Q4 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
219000 USD
CY2021Q4 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-51000 USD
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
86492000 USD
CY2020Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
17048000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
324121000 USD
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
84959000 USD
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
86492000 USD
CY2021Q4 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
5227000 USD
CY2020Q4 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
7026000 USD
CY2021Q4 us-gaap Share Based Compensation
ShareBasedCompensation
29878000 USD
CY2020Q4 us-gaap Share Based Compensation
ShareBasedCompensation
25132000 USD
CY2021Q4 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
3905000 USD
CY2020Q4 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-298000 USD
CY2021Q4 us-gaap Marketable Securities Unrealized Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairments
-592000 USD
CY2020Q4 us-gaap Marketable Securities Unrealized Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairments
1768000 USD
CY2021Q4 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
4115000 USD
CY2020Q4 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
4000000 USD
CY2021Q4 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
325000 USD
CY2020Q4 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-62000 USD
CY2021Q4 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
0 USD
CY2020Q4 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
7334000 USD
CY2021Q4 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-58428000 USD
CY2020Q4 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-33130000 USD
CY2021Q4 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-157000 USD
CY2020Q4 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
7310000 USD
CY2021Q4 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-268000 USD
CY2020Q4 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1479000 USD
CY2021Q4 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-40335000 USD
CY2020Q4 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-46704000 USD
CY2021Q4 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-14904000 USD
CY2020Q4 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-12241000 USD
CY2021Q4 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-7249000 USD
CY2020Q4 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-980000 USD
CY2021Q4 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
124881000 USD
CY2020Q4 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
77947000 USD
CY2021Q4 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
895000 USD
CY2020Q4 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3045000 USD
CY2021Q4 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
129000 USD
CY2020Q4 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
567000 USD
CY2021Q4 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
2763000 USD
CY2020Q4 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
1741000 USD
CY2021Q4 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
2257000 USD
CY2020Q4 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
8291000 USD
CY2021Q4 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
0 USD
CY2020Q4 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
210000 USD
CY2021Q4 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1272000 USD
CY2020Q4 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
3862000 USD
CY2021Q4 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
620000000 USD
CY2020Q4 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
116000000 USD
CY2021Q4 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
788000000 USD
CY2020Q4 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
80000000 USD
CY2021Q4 us-gaap Proceeds From Issuance Of Senior Long Term Debt
ProceedsFromIssuanceOfSeniorLongTermDebt
550000000 USD
CY2020Q4 us-gaap Proceeds From Issuance Of Senior Long Term Debt
ProceedsFromIssuanceOfSeniorLongTermDebt
0 USD
CY2021Q4 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
8200000 USD
CY2020Q4 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0 USD
CY2021Q4 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
0 USD
CY2020Q4 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-176000 USD
CY2021Q4 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
550000 USD
CY2020Q4 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
57000 USD
CY2021Q4 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
47024000 USD
CY2020Q4 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
85678000 USD
CY2021Q4 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
482755000 USD
CY2020Q4 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
50011000 USD
CY2021Q4 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-155429000 USD
CY2020Q4 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-99808000 USD
CY2021Q4 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-1377000 USD
CY2020Q4 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5267000 USD
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-33197000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-12732000 USD
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
195354000 USD
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
157394000 USD
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
162157000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
144662000 USD
CY2021Q4 us-gaap Proceeds From Income Tax Refunds
ProceedsFromIncomeTaxRefunds
72000 USD
CY2020Q4 us-gaap Proceeds From Income Tax Refunds
ProceedsFromIncomeTaxRefunds
221000 USD
CY2021Q4 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1570000 USD
CY2020Q4 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
3186000 USD
CY2021Q4 us-gaap Interest Paid Net
InterestPaidNet
19396000 USD
CY2020Q4 us-gaap Interest Paid Net
InterestPaidNet
17858000 USD
CY2021Q4 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
67000 USD
CY2020Q4 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
13000 USD
CY2021Q4 fico Noncash Unsettled Repurchase Of Common Stock
NoncashUnsettledRepurchaseOfCommonStock
18870000 USD
CY2020Q4 fico Noncash Unsettled Repurchase Of Common Stock
NoncashUnsettledRepurchaseOfCommonStock
0 USD
CY2021Q4 us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top:18pt;text-align:justify;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We make estimates and assumptions that affect the amounts reported in the financial statements and the disclosures made in the accompanying notes. For example, we use estimates in determining the appropriate levels of various accruals; variable considerations included in the transaction price and standalone selling price of each performance obligation for our customer contracts; labor hours in connection with fixed-fee service contracts; the amount of our tax provision; and the realizability of deferred tax assets. We also use estimates in determining the remaining economic lives and carrying values of acquired intangible assets, property and equipment, and other long-lived assets. In addition, we use assumptions to estimate the fair value of reporting units and share-based compensation. Actual results may differ from our estimates.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As the impact of the COVID-19 pandemic continues to evolve, estimates and assumptions about future events and their effects cannot be determined with certainty and therefore require increased judgment. These estimates and assumptions may change in future periods and will be recognized in the condensed consolidated financial statements as new events occur and additional information becomes known. To the extent our actual results differ materially from those estimates and assumptions, our future financial statements could be affected. For more information, see Part II, Item 1A “Risk Factors” of this Quarterly Report on Form 10-Q.</span></div>
CY2021Q4 us-gaap Cash
Cash
162000000 USD
CY2021Q3 us-gaap Cash
Cash
195200000 USD
CY2021Q4 us-gaap Maximum Remaining Maturity Of Foreign Currency Derivatives1
MaximumRemainingMaturityOfForeignCurrencyDerivatives1
P3M
CY2021Q4 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
544000 USD
CY2020Q4 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
937000 USD
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
1541000 USD
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
1100000 USD
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
917000 USD
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
3558000 USD
CY2021Q3 us-gaap Goodwill
Goodwill
788185000 USD
CY2021Q4 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-926000 USD
CY2021Q4 us-gaap Goodwill
Goodwill
787259000 USD
CY2021Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
123516000 USD
CY2021Q3 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
124966000 USD
CY2021Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
98919000 USD
CY2021Q3 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
97053000 USD
CY2021Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
24597000 USD
CY2021Q3 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
27913000 USD
CY2021Q4 us-gaap Accounts Receivable Net Noncurrent
AccountsReceivableNetNoncurrent
30297000 USD
CY2021Q3 us-gaap Accounts Receivable Net Noncurrent
AccountsReceivableNetNoncurrent
37452000 USD
CY2021Q4 us-gaap Capitalized Contract Cost Net Noncurrent
CapitalizedContractCostNetNoncurrent
45998000 USD
CY2021Q3 us-gaap Capitalized Contract Cost Net Noncurrent
CapitalizedContractCostNetNoncurrent
44932000 USD
CY2021Q4 us-gaap Prepaid Expense Noncurrent
PrepaidExpenseNoncurrent
11690000 USD
CY2021Q3 us-gaap Prepaid Expense Noncurrent
PrepaidExpenseNoncurrent
13201000 USD
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
87985000 USD
CY2021Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
95585000 USD
CY2018Q2 us-gaap Line Of Credit Facility Current Borrowing Capacity
LineOfCreditFacilityCurrentBorrowingCapacity
600000000 USD
CY2018Q2 us-gaap Line Of Credit Facility Expiration Date1
LineOfCreditFacilityExpirationDate1
2026-08-19
CY2018Q2 fico Leverage Ratios Maximum
LeverageRatiosMaximum
3.50
CY2018Q2 fico Leverage Ratios Step Up Maximum
LeverageRatiosStepUpMaximum
4.00
CY2018Q2 fico Interestcoverageratio
Interestcoverageratio
3.00
CY2021Q4 us-gaap Line Of Credit
LineOfCredit
300000000 USD
CY2021Q4 us-gaap Line Of Credit Facility Current Borrowing Capacity
LineOfCreditFacilityCurrentBorrowingCapacity
900000000 USD
CY2021Q4 us-gaap Debt Instrument Periodic Payment
DebtInstrumentPeriodicPayment
3750000 USD
CY2021Q4 us-gaap Senior Notes
SeniorNotes
1300000000 USD
CY2021Q4 us-gaap Debt Instrument Fair Value
DebtInstrumentFairValue
1357250000 USD
CY2021Q3 us-gaap Senior Notes
SeniorNotes
750000000 USD
CY2021Q3 us-gaap Debt Instrument Fair Value
DebtInstrumentFairValue
810000000 USD
CY2021Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
322361000 USD
CY2020Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
312414000 USD
CY2021Q4 us-gaap Accounts Receivable Gross
AccountsReceivableGross
138608000 USD
CY2021Q3 us-gaap Accounts Receivable Gross
AccountsReceivableGross
198305000 USD
CY2021Q4 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
156132000 USD
CY2021Q3 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
155408000 USD
CY2021Q4 fico Receivables Gross
ReceivablesGross
294740000 USD
CY2021Q3 fico Receivables Gross
ReceivablesGross
353713000 USD
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
4282000 USD
CY2021Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
4154000 USD
CY2021Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
290458000 USD
CY2021Q3 us-gaap Accounts Receivable Net
AccountsReceivableNet
349559000 USD
CY2021Q4 us-gaap Accounts Receivable Net Noncurrent
AccountsReceivableNetNoncurrent
30297000 USD
CY2021Q3 us-gaap Accounts Receivable Net Noncurrent
AccountsReceivableNetNoncurrent
37452000 USD
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
260161000 USD
CY2021Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
312107000 USD
CY2021Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
110763000 USD
CY2020Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
122141000 USD
CY2021Q4 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
45942000 USD
CY2020Q4 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
47793000 USD
CY2021Q4 fico Contract With Customer Liability Excluding Revenue Recognized
ContractWithCustomerLiabilityExcludingRevenueRecognized
38515000 USD
CY2020Q4 fico Contract With Customer Liability Excluding Revenue Recognized
ContractWithCustomerLiabilityExcludingRevenueRecognized
48441000 USD
CY2021Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
103336000 USD
CY2020Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
122789000 USD
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
98400000 USD
CY2021Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
4900000 USD
CY2021Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
105400000 USD
CY2021Q3 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
5400000 USD
CY2021Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
270600000 USD
CY2021Q4 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.50
CY2021Q4 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P16M
CY2021Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
289000000 USD
CY2021Q4 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.189
CY2020Q4 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.017
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
11800000 USD
CY2021Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
10900000 USD
CY2021Q4 us-gaap Unrecognized Tax Benefits Interest On Income Taxes Accrued
UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued
500000 USD
CY2021Q3 us-gaap Unrecognized Tax Benefits Interest On Income Taxes Accrued
UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued
400000 USD
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
226000 shares
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
205.90
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
9000 shares
CY2021Q4 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
407.49
CY2021Q4 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
7000 shares
CY2021Q4 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
72.06
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
228000 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
218.30
CY2021Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y5M8D
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
50094000 USD
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
179000 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
183.75
CY2021Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P2Y11M8D
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
45033000 USD
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
226000 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
216.50
CY2021Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P3Y5M1D
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
50006000 USD
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
335.16
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
184000 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
407.25
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
210000 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
268.95
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
24000 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
358.29
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
467000 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
392.23
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
84959000 USD
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
86492000 USD
CY2021Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
27167000 shares
CY2020Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
29127000 shares
CY2021Q4 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
357000 shares
CY2020Q4 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
662000 shares
CY2021Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
27524000 shares
CY2020Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
29789000 shares
CY2021Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.13
CY2020Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.97
CY2021Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.09
CY2020Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.90
CY2021Q4 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 Segment
CY2021Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
322361000 USD
CY2021Q4 us-gaap Share Based Compensation
ShareBasedCompensation
29878000 USD
CY2021Q4 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
544000 USD
CY2021Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
115586000 USD
CY2021Q4 us-gaap Interest Expense
InterestExpense
12195000 USD
CY2021Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1429000 USD
CY2021Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
104820000 USD
CY2021Q4 us-gaap Depreciation
Depreciation
4098000 USD
CY2020Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
312414000 USD
CY2020Q4 us-gaap Share Based Compensation
ShareBasedCompensation
25132000 USD
CY2020Q4 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
937000 USD
CY2020Q4 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
7334000 USD
CY2020Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
94721000 USD
CY2020Q4 us-gaap Interest Expense
InterestExpense
9641000 USD
CY2020Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2880000 USD
CY2020Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
87960000 USD
CY2020Q4 us-gaap Depreciation
Depreciation
5585000 USD

Files In Submission

Name View Source Status
0000814547-22-000003-index-headers.html Edgar Link pending
0000814547-22-000003-index.html Edgar Link pending
0000814547-22-000003.txt Edgar Link pending
0000814547-22-000003-xbrl.zip Edgar Link pending
fico-20211231.htm Edgar Link pending
fico-20211231.xsd Edgar Link pending
fico-20211231_cal.xml Edgar Link unprocessable
fico-20211231_def.xml Edgar Link unprocessable
fico-20211231_htm.xml Edgar Link completed
fico-20211231_lab.xml Edgar Link unprocessable
fico-20211231_pre.xml Edgar Link unprocessable
ficoex311q12022.htm Edgar Link pending
ficoex312q12022.htm Edgar Link pending
ficoex321q12022.htm Edgar Link pending
ficoex322q12022.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending